ImmuCell Corporation

NASDAQ: ICCC · Real-Time Price · USD
6.09
-0.63 (-9.38%)
At close: Aug 15, 2025, 3:59 PM
6.19
1.64%
After-hours: Aug 15, 2025, 04:10 PM EDT

ImmuCell Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
8.09B 26.49M 23.84M 23.22M 21.28M 17.47M 16.29M 15.69M 16.01M 18.57M 20.1M 20.46M 21.14M 19.24M 17.54M 16.11M 14.54M
Cost of Revenue
4.73B 18.55M 17.47M 17.17M 15.42M 13.6M 12.68M 11.5M 11.17M 10.92M 10.88M 10.67M 10.98M 10.59M 9.83M 9.09M 8.31M
Gross Profit
3.36B 7.94M 6.37M 6.05M 5.86M 3.87M 3.6M 4.18M 4.85M 7.65M 9.22M 9.79M 10.16M 8.66M 7.72M 7.02M 6.23M
Operating Income
541.97M -575.96M -577.58M -3.87M -3.79M -5.75M -6.38M -5.81M -5.1M -2.05M -271.75K 616.35K 1.42M 257K -522.03K -1.04M -1.95M
Interest Income
46.56K 56.09K 30.67K 46.49K 48.03K 79.13K 143.85K 175.16K 186.54K 153.1K 93.69K 44.21K 23.04K 18.81K 20.59K 19.72K 17.22K
Pretax Income
1.45B -2.15M -3.81M -4.04M -3.89M -5.77M -6.3M -6.01M -5.31M -2.26M -521.8K 285K 1.11M -69K 48.62K -430.08K -1.34M
Net Income
1.45B -2.16M -3.81M -4.05M -3.9M -5.77M -6.3M -6.02M -5.32M -2.27M -529.06K 273.71K 1.1M -78K 36.57K -434.08K -1.34M
Selling & General & Admin
861.01M 5.68M 5.49M 5.45M 5.11M 5.22M 5.6M 5.46M 5.4M 5.23M 4.98M 4.89M 4.56M 4.23M 3.99M 3.74M 3.77M
Research & Development
759.48M 3.9M 4.15M 4.48M 4.55M 4.39M 4.38M 4.53M 4.57M 4.49M 4.54M 4.31M 4.17M 4.17M 4.25M 4.32M 4.41M
Other Expenses
622.84M n/a n/a n/a n/a 107.00 107.00 107.00 167.00 912.00 912.00 796.00 736.00 -116 -116 n/a n/a
Operating Expenses
4.4B 2.17B 2.17B 9.92M 9.66M 9.62M 9.98M 9.99M 9.97M 9.73M 9.52M 9.2M 8.73M 8.4M 8.24M 8.06M 8.18M
Interest Expense
401.11K 547.11K 421.73K 433K 379.2K 323.18K 416.83K 361.64K 363.31K 348.54K 331.67K 320.76K 309.94K 314.36K 237.58K 234.99K 232.63K
Selling & Marketing Expenses
859.32M 3.47M 3.3M 3.27M 3.01M 3.09M 3.41M 3.32M 3.26M 3.19M 3.09M 3.02M 2.79M 2.5M 2.27M 2.08M 2.11M
Cost & Expenses
13.55B 6.61B 6.61B 27.1M 25.07M 23.22M 22.67M 21.5M 21.14M 20.64M 20.4M 19.87M 19.71M 18.99M 18.06M 17.16M 16.49M
Income Tax Expense
3.25M 1.35M 1.34M 4.91K 5.09K 5.28K 5.12K 8.89K 8.51K 8.13K 7.25K 11.3K 10.15K 9K 12.04K 4K 6.53K
Shares Outstanding (Basic)
8.98M 8.94M 8.16M 7.81M 7.75M 7.75M 7.75M 7.67M 7.72M 7.75M 7.75M 7.6M 7.74M 7.66M 7.74M 7.66M 7.22M
Shares Outstanding (Diluted)
8.98M 8.94M 8.16M 7.81M 7.75M 7.75M 7.75M 7.75M 7.75M 7.75M 7.75M 7.74M 7.79M 7.66M 7.82M 7.76M 7.22M
EPS (Basic)
-0.07 -0.28 -0.49 -0.53 -0.51 -0.75 -0.82 -0.78 -0.69 -0.3 -0.07 0.03 0.14 -0.01 0.01 -0.06 -0.19
EPS (Diluted)
-0.07 -0.28 -0.49 -0.53 -0.51 -0.75 -0.82 -0.78 -0.69 -0.3 -0.07 0.04 0.14 -0.01 0.01 -0.06 -0.19
EBITDA
543.31M -573.94M -575.53M -735.54K -603.1K -2.54M -3.21M -3.04M -2.42M 576.44K 2.3M 3.09M 3.89M 2.72M 1.94M 1.44M 475.28K
EBIT
-1.31M -1.6M -3.23M -3.46M -3.36M -5.29M -5.88M -5.65M -4.95M -1.92M -192.39K 605.64K 1.42M 243.28K 197.31K -283.97K -1.19M
Depreciation & Amortization
2.02M 2.69M 2.7M 2.72M 2.76M 2.76M 2.68M 2.61M 2.53M 2.49M 2.49M 2.48M 2.48M 2.47M 2.48M 2.46M 2.41M